Humacyte (HUMA) Short Interest Ratio & Short Volume → Bill Clinton Backing Biden Replacement??? (From The Freeport Society) (Ad) Free HUMA Stock Alerts $5.48 +0.78 (+16.60%) (As of 05/13/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Humacyte Short Interest DataCurrent Short Volume4,490,000 sharesPrevious Short Volume3,940,000 sharesChange Vs. Previous Month+13.96%Dollar Volume Sold Short$17.60 millionShort Interest Ratio / Days to Cover3.2Last Record DateApril 30, 2024Outstanding Shares119,080,000 sharesFloat Size89,920,000 sharesShort Percent of Float4.99%Today's Trading Volume3,855,896 sharesAverage Trading Volume1,157,301 sharesToday's Volume Vs. Average333% Short Selling Humacyte ? Sign up to receive the latest short interest report for Humacyte and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatHUMA Short Interest Over TimeHUMA Days to Cover Over TimeHUMA Percentage of Float Shorted Over Time Ad Porter & CompanyAmerica’s worst nightmare?What This Group Has Planned for the 2024 Election Will Shock You Controversial new exposé reveals what’s really going on in America, what it means for your money, and what you must do to protect your assets before it’s too late.Click here to watch this bombshell exposé now. Humacyte Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20244,490,000 shares $17.60 million +14.0%5.0%3.2 $3.92 4/15/20243,940,000 shares $11.31 million -1.0%4.4%3 $2.87 3/31/20243,980,000 shares $12.38 million +5.3%4.6%4.1 $3.11 3/15/20243,780,000 shares $12.25 million -36.5%4.5%4.3 $3.24 2/29/20245,950,000 shares $25.88 million -9.3%7.0%7.6 $4.35 2/15/20246,560,000 shares $29.26 million +7.0%8.8%12 $4.46 Get the Latest News and Ratings for HUMA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Humacyte and its competitors with MarketBeat's FREE daily newsletter. 1/31/20246,130,000 shares $20.35 million No Change8.2%13 $3.32 1/15/20246,130,000 shares $16.24 million +1.7%8.2%13.7 $2.65 12/31/20236,030,000 shares $17.13 million +8.5%8.1%13.2 $2.84 12/15/20235,560,000 shares $17.18 million -5.3%7.4%12.4 $3.09 11/30/20235,870,000 shares $15.56 million -3.6%7.8%10.9 $2.65 11/15/20236,090,000 shares $15.23 million +10.7%8.1%10.4 $2.50 10/31/20235,500,000 shares $11.66 million +7.8%7.4%7.7 $2.12 10/15/20235,100,000 shares $13.16 million -4.3%6.8%7.7 $2.58 9/30/20235,330,000 shares $15.62 million +1.5%7.1%8.3 $2.93 9/15/20235,250,000 shares $16.98 million +38.2%7.0%7.8 $3.24 8/31/20233,800,000 shares $14.55 million +19.1%5.7%5.5 $3.83 8/15/20233,190,000 shares $14.29 million +6.3%4.9%5.1 $4.48 7/31/20233,000,000 shares $9.84 million No Change4.7%6.3 $3.28 7/15/20233,000,000 shares $9.09 million +2.4%4.7%6.6 $3.03 6/30/20232,930,000 shares $8.38 million -1.7%4.5%6.7 $2.86 6/15/20232,980,000 shares $9.98 million -31.0%5.4%7.8 $3.35 5/31/20234,320,000 shares $14.82 million -21.7%7.6%15.7 $3.43 5/15/20235,520,000 shares $22.00 million +5.8%10.2%21 $3.99 4/30/20235,220,000 shares $16.91 million +0.2%9.7%21.9 $3.24 4/15/20235,210,000 shares $16.93 million -1.0%9.6%23.2 $3.25 3/31/20235,260,000 shares $16.25 million +3.3%9.7%22.6 $3.09 3/15/20235,090,000 shares $14.51 million +2.2%9.4%19 $2.85 2/28/20234,980,000 shares $15.24 million +3.5%9.8%14.7 $3.06 2/15/20234,810,000 shares $15.34 million +7.1%9.4%14.5 $3.19 1/31/20234,490,000 shares $11.81 million +3.0%8.8%13 $2.63 1/15/20234,360,000 shares $10.90 million -4.2%8.6%11.8 $2.50 12/30/20224,550,000 shares $9.60 million +1.6%8.9%11.7 $2.11 12/15/20224,480,000 shares $11.65 million +1.8%8.6%11.4 $2.60 11/30/20224,400,000 shares $13.73 million -4.4%8.5%12.7 $3.12 11/15/20224,600,000 shares $13.66 million -19.3%8.9%12.6 $2.97 10/31/20225,700,000 shares $19.61 million -13.6%11.0%13.8 $3.44 10/15/20226,600,000 shares $20.79 million -17.7%12.7%16.5 $3.15 9/30/20228,020,000 shares $26.15 million +2.0%15.5%19.8 $3.26 9/15/20227,860,000 shares $32.15 million -6.5%15.2%18.1 $4.09Obama’s Forever Term [exposed] (Ad)America’s Last Election New documentary, America’s Last Election, reveals the true (and terrifying) story of how the D.C. establishment has engineered a brutal new crisis that could hand them permanent power. Power they will use to reshape America to their dark, dystopian vision.Start streaming it now at no cost here HUMA Short Interest - Frequently Asked Questions What is Humacyte's current short interest? Short interest is the volume of Humacyte shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 4,490,000 shares of HUMA short. 4.99% of Humacyte's shares are currently sold short. Learn More on Humacyte's current short interest. What is a good short interest ratio for Humacyte? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HUMA shares currently have a short interest ratio of 3.0. Learn More on Humacyte's short interest ratio. What is a good short interest percentage for Humacyte? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.99% of Humacyte's floating shares are currently sold short. Is Humacyte's short interest increasing or decreasing? Humacyte saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 4,490,000 shares, an increase of 14.0% from the previous total of 3,940,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Humacyte's float size? Humacyte currently has issued a total of 119,080,000 shares. Some of Humacyte's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Humacyte currently has a public float of 89,920,000 shares. How does Humacyte's short interest compare to its competitors? 4.99% of Humacyte's shares are currently sold short. Here is how the short interest of companies compare to Humacyte: Valneva SE (0.08%), ProKidney Corp. (22.89%), Alector, Inc. (10.20%), Cabaletta Bio, Inc. (21.90%), Exscientia plc (3.71%), Allogene Therapeutics, Inc. (32.03%), Evolv Technologies Holdings, Inc. (8.20%), Voyager Therapeutics, Inc. (7.74%), C4 Therapeutics, Inc. (14.74%), Editas Medicine, Inc. (24.93%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Humacyte stock? Short selling HUMA is an investing strategy that aims to generate trading profit from Humacyte as its price is falling. HUMA shares are trading up $0.90 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Humacyte? A short squeeze for Humacyte occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HUMA, which in turn drives the price of the stock up even further. How often is Humacyte's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HUMA, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Valneva Short Interest Data ProKidney Short Interest Data Alector Short Interest Data Cabaletta Bio Short Interest Data Exscientia Short Interest Data Allogene Therapeutics Short Interest Data Evolv Technologies Short Interest Data Voyager Therapeutics Short Interest Data C4 Therapeutics Short Interest Data Editas Medicine Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:HUMA) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHow Biden has already won 2024Porter & Company